Nucleus Radiopharmaceuticals News and Resources

Facet Life Sciences has announced its appointment as the official regulatory partner of Nucleus, a company developing diagnostic and therapeutic radiopharmaceuticals. The partnership will focus on providing support with US Food and Drug Administration (FDA) interactions, submissions, and strategic development. The